Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
Earnings call · FY2026 Q2
Executive readout · one minute
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
Forward guidance
4 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Open the source you need; every reader stays inside this workspace.
From the 8-K filed Jul 31, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Revenues
full year 2026
|
$15.1B – $15.43B | — | |
|
Pharmacy Segment Revenue
full year 2026
|
$13.2B – $13.5B | — | |
|
Provider Segment Revenue
full year 2026
|
$1.9B – $1.93B | — | |
|
Total Adjusted EBITDA
full year 2026
|
$820M – $845M | Non-GAAP |
How the reported period landed and where the business moved.
SEC filing · Item 2.02
Filed Jul 31, 2026 · complete as-filed document
SEC periodic report
Filed Jul 31, 2026 · complete as-filed document